Latest Communications

16 January 2013
MonoSol Rx Enters Into Licensing Agreement With Vestiq Pharmaceuticals for Zuplenz(R) Oral Soluble Film

19 November 2012
APR Applied Pharma Research ("APR") and Labtec GmbH ("Labtec") announce the European approval of two new Oral Dispersible Film (ODF) based respectively on Olanzapine and Donepezil

05 October 2012
Stellar Pharmaceuticals Launches New Migraine Treatment, CAMBIA®, in $150 Million Canadian Prescription Migraine Market


topical

TOPICAL PHARMACEUTICALS

Project Design Planning

APR has experience in the topical pharmaceutical formulations development through several classes of drugs and topical pharmaceutical forms; our approach united to our solid background permit us to give you the best and the most complete support starting from galenic phase to a complete CTD Dossier ready for the Registration purpose. Before starting with the technical activities are necessary some steps in order to reduce risks of the development

view more



Integrated project development

The steps usually done for a complete development are the following:

view more


Search results